Autres langues Marksans Pharma Limited

Actions

MARKSANS

INE750C01026

Marché Fermé - NSE India S.E. Autres places de cotation 13:40:30 16/07/2024			Varia. 5j.	Varia. 1 janv.
187,6 ^INR	-0,15 %		+0,32 %	+16,44 %

02/07	Marksans Pharma obtient le feu vert du régulateur britannique pour deux produits	MT
31/05	Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Marksans Pharma Gets UK Regulator's Nod for Two Products	02/07
INDIA STOCKS-Indian shares fall for fifth session on weak global cues, election uncertainties	30/05
Marksans Pharma's Consolidated Profit Declines in Fiscal Q4; Shares Fall 9%	30/05
Marksans Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05
Marksans Pharma Limited Recommends Final Dividend for the Financial Year 2023-24	30/05
Marksans Pharma Gets Marketing Approval for Levetiracetam Relonchem in UK	28/05
Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA	18/04
Marksans Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02
Marksans Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Marksans Pharma Arm Gets UK Regulator's Approval to Market Cyanocobalamin Tablets	06/11
Marksans Pharma Undergoes Successful Inspection from German Health Authorities	01/11
CARE Affirms A+ Rating on Marksans Pharma's Long-term Bank Financing; Outlook Stable	12/10/23
Marksans Pharma Gets US FDA Nod for Esomeprazole Magnesium Delayed-Release Capsules	03/10/23
Marksans Pharma Limited Announces US FDA Approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg	03/10/23
Marksans Pharma Limited Approves Payment of Dividend	28/08/23
Marksans Pharma Limited Appoints Shailaja Vardhan as an Independent Director	28/08/23
Marksans Pharma Gets US FDA's Final Approval for Generic Cough Medicine	22/08/23
Marksans Pharma Ltd. Receives USFDA Approval for Guaifenesin Extended-Release Tablets	22/08/23
Marksans Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23
Marksans Pharma Limited Recommends Payment of Dividend for the Financial Year 2022-23	08/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Marksans Pharma Limited

Actions

MARKSANS

INE750C01026

Autres langues

Filtres